A photo of Phillipe Backeljauw.

Director, Pediatric Endocrinology Fellowship Program

Director, Cincinnati Center for Pediatric and Adult Turner Syndrome Care

Clinical Director, Growth Disorders Center

Professor, UC Department of Pediatrics



Board Certified

Best Doctors logo

My Biography & Research


Professor Backeljauw is engaged in clinical research related to growth disorders and Turner syndrome. He is a collaborator in several ongoing studies, including several projects related to Turner syndrome and its co-morbidities. The Cincinnati Center for Pediatric and Adult Turner Syndrome Care is perhaps the largest Turner syndrome center in the United States and provides comprehensive clinical care to patients with Turner syndrome across their lifespan. In 2017 he was the senior author on the new guidelines for clinical care for girls and women with Turner syndrome, after organizing (with Claus Gravholt) an international society-sponsored consensus meeting for this.

Dr. Backeljauw has published more than 90 peer-reviewed manuscripts and more than 100 abstracts, 17 textbook chapters, and has given more than 90 invited presentations at national and international meetings. As major scientific contribution one may include that he was the PI (together with Louis Underwood and Steven Chernausek) on the long-term studies with patients with growth hormone insensitivity syndrome (growth hormone resistance) between 1992 and 2013. He was the first in the world to treat these growth hormone resistant patients long term, and the data from these studies eventually brought recombinant human IGF-1 to USFDA and EMA approval.

Additional Languages

French, Spanish

Academic Affiliation

Professor, UC Department of Pediatrics


Endocrinology, Diabetes, Endocrinology

My Locations

My Education

MD: University of Ghent, Belgium.

Residency: Pediatric and Adolescent Medicine, Cleveland Clinic Foundation Children's Hospital, Cleveland, OH.

Fellowship: Pediatric Endocrinology, University of North Carolina, Chapel Hill, NC.

Certification: Pediatrics, 1992; recertified, 1999, 2007; Pediatric Endocrinology, 1995; recertified, 2003, 2013.

My Publications

45,X mosaicism in a population-based biobank: implications for Turner syndrome. Prakash, SK; Crenshaw, ML; Backeljauw, PF; Silberbach, M; Scurlock, C; Culin, DD; Ranallo, KC; Lin, AE. Genetics in Medicine. 2019; 21:1882-1883.

Proposed endocrine funding priorities for the NICHD strategic plan: expert opinion from the Pediatric Endocrine Society. Singer, K; Katz, ML; Mittelman, SD; Gubitosi-Klug, R; Muzumdar, R; Chan, Y; Davis, S; De Leon-Crutchlow, D; Rother, K; Zeitler, P; et al. Pediatric Research. 2019; 86:141-143.

Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action. Storr, HL; Chatterjee, S; Metherell, LA; Foley, C; Rosenfeld, RG; Backeljauw, PF; Dauber, A; Savage, MO; Hwa, V. Endocrine Reviews. 2019; 40:476-505.

Sex hormone replacement therapy for individuals with Turner syndrome. Backeljauw, P; Klein, K. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics. 2019; 181:79-83.

Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium. Bangalore Krishna, K; Fuqua, JS; Rogol, AD; Klein, KO; Popovic, J; Houk, CP; Charmandari, E; Lee, PA. Hormone Research in Paediatrics: from developmental endocrinology to clinical research. 2019; 91:357-372.

Impaired aortic distensibility and elevated central blood pressure in Turner Syndrome: a cardiovascular magnetic resonance study. Wen, J; Trolle, C; Viuff, MH; Ringgaard, S; Laugesen, E; Gutmark, EJ; Subramaniam, DR; Backeljauw, P; Gutmark-Little, I; Andersen, NH; et al. Journal of Cardiovascular Magnetic Resonance. 2018; 20.

Toward More Targeted and Cost-Effective Gonadotropin-Releasing Hormone Analog Treatment in Girls with Central Precocious Puberty. Kaplowitz, PB; Backeljauw, PF; Allen, DB. Hormone Research in Paediatrics: from developmental endocrinology to clinical research. 2018; 90:1-7.

Growth Hormone Therapy for Turner Syndrome. Blunden, C; Nasomyont, N; Backeljauw, P. Pediatric Endocrinology Reviews PER. 2018; 16:80-90.

Bone fragility in Turner syndrome: Fracture prevalence and risk factors determined by a national patient survey. Wasserman, H; Backeljauw, PF; Khoury, JC; Kalkwarf, HJ; Gordon, CM. Clinical Endocrinology. 2018; 89:46-55.

Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations. Klein, KO; Rosenfield, RL; Santen, RJ; Gawlik, AM; Backeljauw, PF; Gravholt, CH; Sas, TC J; Mauras, N. Journal of Clinical Endocrinology and Metabolism. 2018; 103:1790-1803.